77 related articles for article (PubMed ID: 23857669)
1. Relationship of psychological symptoms, antipsychotics and social data with psychosocial function in schizophrenia patients in Malaysia.
Norlelawati AT; Kartini A; Norsidah K; Ramli M; Wan Azizi WS; Tariq AR
Asia Pac Psychiatry; 2015 Mar; 7(1):45-53. PubMed ID: 23857669
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
[TBL] [Abstract][Full Text] [Related]
3. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
4. Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study.
Guo X; Zhang Z; Zhai J; Fang M; Hu M; Wu R; Liu Z; Zhao J;
Compr Psychiatry; 2012 Oct; 53(7):1006-12. PubMed ID: 22516246
[TBL] [Abstract][Full Text] [Related]
5. [Quality of life in patients with schizophrenia: a study of 100 cases].
Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
[TBL] [Abstract][Full Text] [Related]
6. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
Herrera-Estrella M; Apiquian R; Fresan A; Sanchez-Torres I
BMC Psychiatry; 2005 May; 5():22. PubMed ID: 15869707
[TBL] [Abstract][Full Text] [Related]
7. Obesity in multiracial schizophrenia patients receiving outpatient treatment in a regional tertiary hospital in malaysia.
Norlelawati AT; Kartini A; Ramli M; Norsidah K; Wan Azizi WS; Tariq AR
East Asian Arch Psychiatry; 2012 Jun; 22(2):49-56. PubMed ID: 22714874
[TBL] [Abstract][Full Text] [Related]
8. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.
Hunter R; Barry S
Eur Psychiatry; 2012 Aug; 27(6):432-6. PubMed ID: 21602034
[TBL] [Abstract][Full Text] [Related]
9. Outcome study of first-episode schizophrenia in a developing country: quality of life and antipsychotics.
Chee KY
Soc Psychiatry Psychiatr Epidemiol; 2009 Feb; 44(2):143-50. PubMed ID: 18642120
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial rehabilitation activities, empowerment, and quality of community-based life for people with schizophrenia.
Chou KR; Shih YW; Chang C; Chou YY; Hu WH; Cheng JS; Yang CY; Hsieh CJ
Arch Psychiatr Nurs; 2012 Aug; 26(4):285-94. PubMed ID: 22835748
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
13. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
Burton S
J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
[TBL] [Abstract][Full Text] [Related]
14. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
[TBL] [Abstract][Full Text] [Related]
15. Predictors of quality of life in inpatients with schizophrenia.
Fujimaki K; Morinobu S; Yamashita H; Takahashi T; Yamawaki S
Psychiatry Res; 2012 May; 197(3):199-205. PubMed ID: 22370148
[TBL] [Abstract][Full Text] [Related]
16. Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Sugita AI; Atake K; Nakamura J
J Psychiatr Res; 2013 Dec; 47(12):1843-8. PubMed ID: 24054464
[TBL] [Abstract][Full Text] [Related]
17. Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics.
Tyson PJ; Laws KR; Flowers KA; Tyson A; Mortimer AM
Psychiatry Clin Neurosci; 2006 Aug; 60(4):473-9. PubMed ID: 16884450
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
19. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
Kurtz MM; Moberg PJ; Ragland JD; Gur RC; Gur RE
Schizophr Bull; 2005 Jan; 31(1):167-74. PubMed ID: 15888434
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
